These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32234026)

  • 1. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease.
    Molina-Andújar A; Robles P; Cibeira MT; Montagud-Marrahi E; Guillen E; Xipell M; Blasco M; Poch E; Rosiñol L; Bladé J; Quintana LF
    BMC Nephrol; 2020 Mar; 21(1):111. PubMed ID: 32234026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of serum-free light-chain levels with markers of renal function.
    Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
    Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
    Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications.
    Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS
    Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Value of sFLC and Serum Calcium in the Diagnosis and Prognosis of Multiple Myeloma Patients].
    Pei XH; Zhang LN; Zhou P; Wang TB; Lian C; Zhang P; Lei PC; Zhu ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):794-798. PubMed ID: 38926969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.
    Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L
    Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease.
    Niewmierzycka A; Kurman M; Leśniak M; Winiarska A; Pawłowska A
    Pol Arch Med Wewn; 2015; 125(7-8):532-7. PubMed ID: 26038841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular filtration rate as a determinant of free light chains in renal transplantation.
    Bargnoux AS; Simon N; Garrigue V; Dupuy AM; Badiou S; Mourad G; Cristol JP
    Clin Biochem; 2013 Nov; 46(16-17):1764-6. PubMed ID: 24028899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma].
    Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma].
    Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma.
    Iwama K; Chihara D; Tsuda K; Ugai T; Sugihara H; Nishida Y; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Feb; 90(2):134-41. PubMed ID: 23210517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients.
    Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M
    J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
    Zhao D; Jiang JQ; Lin L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study.
    Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N
    Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.
    Hutchison CA; Harding S; Hewins P; Mead GP; Townsend J; Bradwell AR; Cockwell P
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1684-90. PubMed ID: 18945993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-house age-specific reference ranges for free light chains measured on the SPAPlus® analyser.
    Campbell L; Simpson D; Shields A; Ferry B; Ramasamy K; Sadler R
    Ann Clin Biochem; 2020 Mar; 57(2):138-143. PubMed ID: 31852213
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR.
    Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J
    Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use.
    Hansen CT; Münster AM; Nielsen L; Pedersen P; Abildgaard N
    Eur J Haematol; 2012 Dec; 89(6):458-68. PubMed ID: 22998393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
    Böer K; Deufel T
    Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.